Many people in the arthritis community have already heard this interesting news: hydroxychloroquine (Plaquenil) - a medication routinely used to treat rheumatoid arthritis, juvenile idiopathic arthritis, and lupus - is now being considered as a potential treatment for COVID19.
Stefano Volinia, a scientist at the University of Ferrara in Italy, is interested in learning more about this potential treatment. He sent me an email saying that he thinks scientists can learn a lot about the efficacy of this drug towards COVID19 simply by assessing the spread of the virus among patients who already use these medications routinely. He asked me to share a quick survey - only 3 questions, plus age and gender - with my community of individuals living with arthritis to help with their efforts. Here is his message:
Help the world fight Coronavirus!
Do you use Plaquenil, Aralan, or chloroquine?
A common drug, called Plaquenil, has been shown by scientists to block the coronavirus in test tubes. Many people worldwide use this drug, or its generic hydroxychloroquine (HCQ), to treat lupus erythematosus or rheumatoid arthritis. Other people use a similar drug (Aralen), chloroquine, for malaria or Amebiasis.
I work at the University of Ferrara (Italy). Like many other nations in the world, we are now hit hard by coronavirus. The hospitals are more and more stressed by the ever increasing number of patients. The pandemic is now expanding worldwide. Large scale studies for the efficacy of this drug against Coronavirus are not yet available. Even if you are not using any of these drugs, you can be part of the solution!
Simply answer 3 questions and help to stop this deadly disease, called COVID-19!
Please share this survey with anyone who might be able to help!